Skip to content

Investigation of postoperative constipation in patients with urinary system neoplasms

Investigation of postoperative constipation in patients with urinary system neoplasms

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042876
Enrollment
Unknown
Registered
2021-01-30
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation

Interventions

case series:Nil

Sponsors

Cancer Hospital Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male or female between 18 and 80 years of age; 2. A patient with a urinary tract tumor undergoing surgical resection; 3. Patients voluntarily participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. 5 times of the upper normal value of > for aspartate aminotransferase (AST) or alanine aminotransferase (ALT); 2. Serum creatinine value of > is 2 times the upper limit of normal; 3. Paraplegia or tumor compression of the rectum due to trauma or surgery caused by defecation disorders; 4. Mental or neurological disorders, unable to express their wishes correctly; 5. Pregnant women, lactating women and women of childbearing age who do not take contraceptive measures; 6. Those deemed unsuitable for inclusion by the investigator.

Design outcomes

Primary

MeasureTime frame
Percentage of patients with spontaneous complete bowel movements (SCBM >= 3 times within 7 days of prevention or treatment during the survey period (SCBM >= 3 times is considered normal bowel movements);

Secondary

MeasureTime frame
Compared with before treatment, the proportion of patients with SCBM more than once within 7 days of prevention or treatment increased;Proportion of patients with SCBM or SBM within 7 days of prevention or treatment;Difference in constipation symptom scores at 7 days of prevention or treatment compared with pre-medication;Compared with before treatment, the proportion of patients whose QOL score of constipation patients improved by more than 1 after 7 days of prevention or treatment;incidence of adverse events related to cathartic;

Countries

China

Contacts

Public ContactNianzeng Xing

Cancer Hospital Chinese Academy of Medical Sciences

nianzeng2006@vip.sina.com+86 18601238866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026